KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Labcorp Holdings (LH) EBT Margin (2016 - 2025)

Historic EBT Margin for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to 9.46%.

  • Labcorp Holdings' EBT Margin rose 30400.0% to 9.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.0%, marking a year-over-year increase of 30500.0%. This contributed to the annual value of 7.38% for FY2024, which is 27000.0% up from last year.
  • According to the latest figures from Q3 2025, Labcorp Holdings' EBT Margin is 9.46%, which was up 30400.0% from 8.64% recorded in Q2 2025.
  • In the past 5 years, Labcorp Holdings' EBT Margin registered a high of 41.73% during Q4 2021, and its lowest value of 4.85% during Q4 2023.
  • For the 5-year period, Labcorp Holdings' EBT Margin averaged around 11.41%, with its median value being 8.96% (2023).
  • As far as peak fluctuations go, Labcorp Holdings' EBT Margin soared by 340300bps in 2021, and later crashed by -413800bps in 2022.
  • Quarter analysis of 5 years shows Labcorp Holdings' EBT Margin stood at 41.73% in 2021, then plummeted by -99bps to 0.35% in 2022, then tumbled by -1493bps to 4.85% in 2023, then soared by 214bps to 5.52% in 2024, then soared by 71bps to 9.46% in 2025.
  • Its EBT Margin was 9.46% in Q3 2025, compared to 8.64% in Q2 2025 and 8.23% in Q1 2025.